Vertex Pharmaceuticals (VRTX)
$180.18
4.06 (2.20%)
VRTX Stock Quote Delayed 15 Minutes
Previous Close
$180.18
Market Cap
45.92B
PE Ratio
209.51
EPS
0.86
Volume (Avg. Vol.)
1.20M
Day's Range
179.24 - 186.78
52-Week Range
151.80 - 195.81
Dividend & Yield
N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
3 Stocks to Watch on Thursday: Mondelez International Inc (MDLZ), Paypal Holdings Inc (PYPL) and Vertex Pharmaceuticals Incorporated (VRTX)
Mondelez (MDLZ) beat earnings expectations, Paypal (PYPL) revenue grew 24% and Vertex Pharmaceuticals' (VRTX) adjusted income up 74%.
Vertex Pharmaceuticals (VRTX) a Buy on Healthy Sales Growth
Currently, Vertex Pharmaceuticals Inc (NASDAQ:VRTX) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
